ADMA Biologics, Inc. ADMA
Set alert
11.06 USD -0.35 -3.07%
At close
11.29 +0.23 +2.08%
Pre-market · Nov 3, 4:13 AM ET
11.05 Day range 11.59
7.21 52-week range 20.46
- YTD
- -39.36%
- 1 year
- -28.04%
- Open
- 11.42
- Prev close
- 11.41
- Mkt cap
- 2.48B
- Vol
- 2.89M
- Avg vol
- 2.69M
- EPS
- 0.70
- P/E
- 15.80
- Div yield
- 0.00%
More statistics
- Low
- 11.05
- High
- 11.59
- Forward P/E
- 11.72
- Beta
- 0.66
- Short ratio
- 5.82
- Inst. own
- 92.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 10.00
- 200-d avg
- 10.96
- 1y target
- 17.00
Analyst view
Consensus: none
Price target (mean) 17.00 +53.7% upside
Now 11.06
- Target (low)
- 12.00
- Target (mean)
- 17.00
- Target (high)
- 21.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
- Strong buy1
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.19667 | 0.19 – 0.20 | 0.15902 | +23.7% | 138.12M | +2.9% | 3 |
| Next quarter | 0.24333 | 0.22 – 0.27 | 0.2157 | +12.8% | 158.40M | +13.8% | 3 |
| Current year | 0.79667 | 0.77 – 0.83 | 0.6567 | +21.3% | 535.35M | +4.9% | 3 |
| Next year | 0.94333 | 0.81 – 1.03 | 0.79667 | +18.4% | 629.54M | +17.6% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| May 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 7, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Apr 21, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Apr 13, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Mar 26, 2026 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| May 8, 2025 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Mar 4, 2025 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 8, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 8, 2024 | Raymond James | Maintained | Strong Buy | Strong Buy |
| Oct 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 20, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 12, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 9, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jul 9, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jun 20, 2024 | Mizuho | Maintained | Buy | Buy |
| May 10, 2024 | Raymond James | Maintained | Strong Buy | Strong Buy |
| May 10, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| May 10, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 10, 2024 | Mizuho | Maintained | Buy | Buy |
| Mar 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 1, 2024 | Mizuho | Maintained | Buy | Buy |
| Feb 29, 2024 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Feb 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 22, 2024 | Mizuho | Maintained | Buy | Buy |
| Jan 9, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 19, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 10, 2023 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 10, 2023 | Raymond James | Maintained | Strong Buy | Strong Buy |